top of page

AAO 2024 RETINA SHOWCASE


Moderators: Robert Avery, MD and Allen C. Ho, MD 
Panel: Wiley Chambers, MD, Mark Humayun, MD, PhD, and Namrata Saroj, OD

Location: Room E450a

Start
Company
Presenter
1:15 PM
Introduction
Robert Avery, MD
1:17 PM
Aura Biosciences, Inc.
J. Jill Hopkins, MD, FRCSC, CMO & President of R & D
1:22 PM
Discussion
1:24 PM
Ocular Therapeutix
Peter Kaiser, MD, Chief Development Officer
1:29 PM
Discussion
1:31 PM
ONL Therapeutics
David Zacks, MD, PhD, Co-Founder and Chief Scientific Officer
1:36 PM
Discussion
1:38 PM
Adverum Biotechnologies, Inc.
Laurent Fischer, MD, CEO
1:43 PM
Discussion
1:45 PM
Aviceda Therapeutics Inc.
Tarek Hassan, MD, Chief Development Officer
1:50 PM
Discussion
1:52 PM
Clearside Biomedical, Inc.
Victor Chong, MD, MBA, Chief Medical Officer
1:57 PM
Discussion
1:59 PM
Eyepoint Pharmaceuticals
Jay S. Duker, MD, President & CEO and Board Director
2:04 PM
Discussion
2:06 PM
Oculis
Riad Sherif, MD, CEO
2:11 PM
Discussion
2:13 PM
REGENXBIO, Inc.
Sumie Takahara, Executive Director, Global Product and Market Planning
2:18 PM
Discussion
2:20 PM
4D Molecular Therapeutics, Inc.
Robert Kim, MD, Chief Medical Officer
2:25 PM
Discussion
2:27 PM
Annexon Biosciences
Doug Love, President & CEO
2:32 PM
Discussion
2:34 PM
Nanoscope Therapeutics
Sam Barone, MD, Chieft Medical Officer
2:39 PM
Discussion
2:41 PM
Kiora Pharmaceuticals
Brian M Strem, PhD, CEO
2:46 PM
Discussion
2:51 PM
Visgenx, Inc.
William Pedronti, CEO
2:53 PM
Discussion
2:55 PM
Conclusion
Allen C. Ho, MD
bottom of page